Browsing by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 11063 to 11082 of 25616 < previous   next >
TitleAuthor(s)Issue date
P - γλυκοπρωτεΐνη και άλλοι μοριακοί δείκτες στο οστεοσάρκωμα : μετα-αναλυτική προσέγγισηΠάκος, Αιμίλιος Ε.20-Nov-2015
P-31 solid-state NMR measurements used to detect interactions between NADPH and water and to determine the ionisation state of NADPH in a protein-ligand complex subjected to low-level hydrationGerothanassis, I. P.; Barrie, P. J.; Birdsall, B.; Feeney, J.24-Nov-2015
p-hydroquinone-metal compounds: synthesis and crystal structure of two novel V-V-p-hydroquinonate and V-IV-p-semiquinonate speciesDrouza, C.; Tolis, V.; Gramlich, V.; Raptopoulou, C.; Terzis, A.; Sigalas, M. P.; Kabanos, T. A.; Keramidas, A. D.24-Nov-2015
P-tree structures and event horizon: Efficient event-set implementationsAsdre, K.; Nikolopoulos, S. D.24-Nov-2015
P0 glycoprotein peptides 56-71 and 180-199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreadingZhu, J.; Pelidou, S. H.; Deretzi, G.; Levi, M.; Mix, E.; van der Meide, P.; Winblad, B.; Zou, L. P.24-Nov-2015
p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysisTsoumpou, I.; Arbyn, M.; Kyrgiou, M.; Wentzensen, N.; Koliopoulos, G.; Martin-Hirsch, P.; Malamou-Mitsi, V.; Paraskevaidis, E.24-Nov-2015
p16INK4A is regularly expressed in Hodgkin's disease: comparison with retinoblastoma, p53 and MDM2 protein status, and the presence of Epstein-Barr virusGuenova, M.; Rassidakis, G. Z.; Gorgoulis, V. G.; Angelopoulou, M. K.; Siakantaris, M. R.; Kanavaros, P.; Pangalis, G. A.; Kittas, C.24-Nov-2015
P21(waf1/cip1) protein expression in normal, hyperplastic and malignant endometrium. Correlation with hormone receptor status, c-erbB-2 oncoprotein, bcl-2 and other cell cycle related proteins (Rb, p53, Ki-67, PCNA)Ioachim, E.; Kitsiou, E.; Mitselou, A.; Zagorianakou, N.; Charalabopoulos, K.; Salmas, M.; Makrydimas, G.; Vougiouklakis, T.; Agnantis, N. J.24-Nov-2015
P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expressionKouvidou, C.; Stefanaki, K.; Dai, Y.; Tzardi, M.; Koutsoubi, K.; Darivianaki, K.; Karidi, E.; Rontogianni, D.; Zois, E.; Kakolyris, S.; Georgoulias, V.; Delides, G.; Kanavaros, P.24-Nov-2015
p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stageSkopelitou, A.; Hadjiyannakis, M.; Dimopoulos, D.; Kamina, S.; Krikoni, O.; Alexopoulou, V.; Rigas, C.; Agnantis, N. J.24-Nov-2015
p53 enhances the Delta-24 conditionally replicative adenovirus anti-glioma effectMitlianga, P. G.; Sioka, C.; Vartholomatos, G.; Goussia, A.; Polyzoidis, K.; Rao, J. S.; Kyritsis, A. P.24-Nov-2015
P53 expression in patients with malignant and benign breast diseasesKalogeraki, A.; Panayiotides, J.; Tamiolakis, D.; Tzardi, M.; Chaniotis, V.; Chalkiadakis, G.; Melissas, J.; Stiftsis, D.; Kanavaros, P.; Delides, G. S.24-Nov-2015
p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1Giannikaki, E.; Kouvidou, C.; Tzardi, M.; Stefanaki, K.; Koutsoubi, K.; Gregoriou, M.; Zois, E.; Kakolyris, S.; Mavroudi, C.; Delides, G.; Georgoulias, V.; Kanavaros, P.24-Nov-2015
p53 protein expression in non-Hodgkin's lymphoma. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1Tzardi, M.; Kouvidou, C.; Panayiotides, I.; Stefanaki, K.; Rontogianni, D.; Zois, E.; Koutsoubi, K.; Eliopoulos, G.; Delides, G.; Kanavaros, P.24-Nov-2015
p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up studyStefanou, D. G.; Nonni, A. V.; Agnantis, N. J.; Athanassiadou, S.; Briassoulis, E.; Pavlidis, N.24-Nov-2015
p63 expression in benign and malignant breast lesionsStefanou, D.; Batistatou, A.; Nonni, A.; Arkoumani, E.; Agnantis, N. J.24-Nov-2015
Pacemaker dependency after implantation of electrophysiological devicesKorantzopoulos, P.; Letsas, K. P.; Grekas, G.; Goudevenos, J. A.24-Nov-2015
Pacemaker-induced superior vena cava syndrome: report of four cases and review of the literatureGoudevenos, J. A.; Reid, P. G.; Adams, P. C.; Holden, M. P.; Williams, D. O.24-Nov-2015
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)Kosmidis, P.; Mylonakis, N.; Skarlos, D.; Samantas, E.; Dimopoulos, M.; Papadimitriou, C.; Kalophonos, C.; Pavlidis, N.; Nikolaidis, C.; Papaconstantinou, C.; Fountzilas, G.24-Nov-2015
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized studyKosmidis, P.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanassiadis, A.; Pavlidis, N.; Skarlos, D.24-Nov-2015